Back to Rankings

PLRX

Pliant TherapeuticsA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
PLRX vs peer average
95/100
PLRX vs. peer average (A vs. D)
Grade spread
B 1 · C 1 · D 4 · F 4
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

ACET is the first available peer comparator.

Small-cap biotech peer used only as a loose event-risk comparator: like PLRX, valuation can swing on clinical updates, safety signals, and cash runway, but it is not a direct indication or mechanism peer.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerACETAdicet Bio
PLRX
Pliant Therapeutics
ACET
Adicet Bio
Grade
A
F
Momentum
96
21
Value
58
59
Sentiment
97
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs ACET

PLRX / ACET
Grade Position
Above peers
PLRX vs. peer average (A vs. D)
95/100
Momentum
96
PLRX
Value
58
ACET
Sentiment
97
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs PLRX
1
ACET
ACET
F
20/100
+4
2
GANX
GANX
B
80/100
+1
3
MCRB
Seres Therapeutics Inc Common
D
40/100
+3
4
CTOR
Citius Oncology Inc Common
F
20/100
+4
5
XBIT
XBiotech Inc Common
D
40/100
+3
ACET is the first peer returned for this comparison set.